XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net (loss) income $ (807) $ 383
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Net loss (gain) from securities transactions 538 (178)
Purchases of securities (634) (883)
Proceeds from sales of securities 3,905 4,920
Payments to cover securities sold, not yet purchased (3,919) (2,623)
Proceeds from securities sold, not yet purchased 951 2,925
Changes in receivables and payables relating to securities transactions 2,094 (768)
Changes in derivative assets and liabilities 802 (966)
Loss on disposition of assets, net (5) (3)
Depreciation and amortization 384 380
Loss on deconsolidation of subsidiary 246  
Credit loss expense 139  
Deferred taxes (76) (44)
Other, net 16 48
Changes in other operating assets and liabilities (13) 149
Net cash provided by operating activities 3,621 3,340
Cash flows from investing activities:    
Capital expenditures (201) (254)
Turnaround expenditures (53) (74)
Proceeds from partial sale of interests in consolidated subsidiaries 158  
Proceeds from sale of investments   153
Proceeds from disposition of businesses and assets 4 4
Other, net 11  
Net cash used in investing activities (81) (171)
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests   6
Investment segment distributions to non-controlling interests (2,033) (20)
Partnership contributions 185 560
Partnership distributions (194) (162)
Dividends and distributions to non-controlling interests in subsidiaries (241) (218)
Repayments of Holding Company senior unsecured notes   (500)
Proceeds from subsidiary borrowings 36 91
Repayments of subsidiary borrowings (63) (155)
Other, net (4) (5)
Net cash used in financing activities (2,314) (403)
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents   8
Net increase in cash and cash equivalents and restricted cash and restricted cash equivalents 1,226 2,774
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 4,886 4,436
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 6,112 $ 7,210